Ignite Creation Date:
2024-05-06 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 12:46 PM
Study NCT ID:
NCT03540160
Status:
TERMINATED
Last Update Posted:
2021-05-20
First Post:
2018-04-05
Brief Title:
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus Itch
Sponsor:
Vyne Therapeutics Inc
Organization:
Vyne Therapeutics Inc
Study Overview
Official Title:
An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus
Status:
TERMINATED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No longer pursuing development of serlopitant
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study of the long term safety of serlopitant for the treatment of pruritus in adults
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2017-004211-40 | EUDRACT_NUMBER | None | None |